Logo image of INCR

INTERCURE LTD (INCR) Stock Price, Quote, News and Overview

NASDAQ:INCR - Nasdaq - IL0011063760 - Common Stock - Currency: USD

1.54  +0.06 (+4.05%)

After market: 1.48 -0.06 (-3.9%)

INCR Quote, Performance and Key Statistics

INTERCURE LTD

NASDAQ:INCR (4/28/2025, 8:17:01 PM)

After market: 1.48 -0.06 (-3.9%)

1.54

+0.06 (+4.05%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High3.72
52 Week Low1.17
Market Cap72.63M
Shares47.16M
Float29.04M
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)05-19 2025-05-19
IPO07-26 2007-07-26


INCR short term performance overview.The bars show the price performance of INCR in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20

INCR long term performance overview.The bars show the price performance of INCR in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of INCR is 1.54 USD. In the past month the price increased by 9.22%. In the past year, price decreased by -50.64%.

INTERCURE LTD / INCR Daily stock chart

INCR Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 67.48 831.66B
JNJ JOHNSON & JOHNSON 15.46 374.37B
NVO NOVO-NORDISK A/S-SPONS ADR 18.15 277.97B
NVS NOVARTIS AG-SPONSORED ADR 14.19 222.45B
AZN ASTRAZENECA PLC-SPONS ADR 16.85 216.81B
MRK MERCK & CO. INC. 10.68 209.34B
PFE PFIZER INC 7.41 130.73B
SNY SANOFI-ADR 13.7 129.16B
BMY BRISTOL-MYERS SQUIBB CO 6.6 98.60B
GSK GSK PLC-SPON ADR 8.75 77.12B
ZTS ZOETIS INC 25.94 68.50B
TAK TAKEDA PHARMACEUTIC-SP ADR 32.96 47.71B

About INCR

Company Profile

INCR logo image InterCure Ltd. engages in the provision of business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

Company Info

INTERCURE LTD

Medinat HaYehudim 85

Herzliya 27604 IL

CEO: Alistair Macdonald

Employees: 270

Company Website: https://www.intercure.co/

Investor Relations: http://www.intercure.co/resources/investor-faqs

Phone: 972774605012

INTERCURE LTD / INCR FAQ

What is the stock price of INTERCURE LTD today?

The current stock price of INCR is 1.54 USD. The price increased by 4.05% in the last trading session.


What is the ticker symbol for INTERCURE LTD stock?

The exchange symbol of INTERCURE LTD is INCR and it is listed on the Nasdaq exchange.


On which exchange is INCR stock listed?

INCR stock is listed on the Nasdaq exchange.


What is INTERCURE LTD worth?

INTERCURE LTD (INCR) has a market capitalization of 72.63M USD. This makes INCR a Micro Cap stock.


How many employees does INTERCURE LTD have?

INTERCURE LTD (INCR) currently has 270 employees.


What are the support and resistance levels for INTERCURE LTD (INCR) stock?

INTERCURE LTD (INCR) has a support level at 1.39 and a resistance level at 1.59. Check the full technical report for a detailed analysis of INCR support and resistance levels.


Is INTERCURE LTD (INCR) expected to grow?

The Revenue of INTERCURE LTD (INCR) is expected to decline by -24.35% in the next year. Check the estimates tab for more information on the INCR EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy INTERCURE LTD (INCR) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does INTERCURE LTD (INCR) stock pay dividends?

INCR does not pay a dividend.


When does INTERCURE LTD (INCR) report earnings?

INTERCURE LTD (INCR) will report earnings on 2025-05-19.


What is the Price/Earnings (PE) ratio of INTERCURE LTD (INCR)?

INTERCURE LTD (INCR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.38).


What is the Short Interest ratio of INTERCURE LTD (INCR) stock?

The outstanding short interest for INTERCURE LTD (INCR) is 0.12% of its float. Check the ownership tab for more information on the INCR short interest.


INCR Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to INCR. When comparing the yearly performance of all stocks, INCR is a bad performer in the overall market: 82.94% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

INCR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to INCR. INCR may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

INCR Financial Highlights

Over the last trailing twelve months INCR reported a non-GAAP Earnings per Share(EPS) of -0.38. The EPS decreased by -237.58% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -7.88%
ROE -13.61%
Debt/Equity 0.23
Chartmill High Growth Momentum
EPS Q2Q%-822.04%
Sales Q2Q%236.68%
EPS 1Y (TTM)-237.58%
Revenue 1Y (TTM)-8.52%

INCR Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 83% to INCR. The Buy consensus is the average rating of analysts ratings from 7 analysts.

For the next year, analysts expect an EPS growth of 90.7% and a revenue growth -24.35% for INCR


Ownership
Inst Owners10.95%
Ins Owners38.42%
Short Float %0.12%
Short Ratio1.51
Analysts
Analysts82.86
Price TargetN/A
EPS Next Y90.7%
Revenue Next Year-24.35%